全球藥物研發服務市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計藥物研發服務市場將從 2025 年的 260.4 億美元成長到 2034 年的 928.3 億美元，2026 年至 2034 年的複合年成長率為 15.17%。

由於多個疾病領域對新型有效療法的需求不斷成長，全球藥物研發服務市場正在快速擴張。製藥和生技公司擴大將藥物研發流程外包給專業服務供應商，以降低成本並縮短研發週期。這些服務包括標靶分子鑑定、先導化合物最佳化、篩檢和臨床前研究。

人工智慧（AI）、高通量篩檢和先進生物資訊學等技術進步正在改變藥物發現過程。這些技術使研究人員能夠分析大規模資料集，以高效識別有前景的候選藥物，並縮短藥物開發所需的整體時間。因此，能力卓越的外部合作夥伴在製藥生態系統中日益重要。

受創新藥物需求持續成長的推動，藥物研發服務市場前景依然強勁。生物技術研究投入的增加、藥物研發管線的不斷拓展以及慢性病盛行率的上升，預計都將支持市場成長。製藥公司與專業研究機構之間的合作將進一步加速該領域的擴張。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球藥物研發服務市場：依流程分類

• 市場分析、洞察與預測
• 目標選擇
• 目標檢驗
• 將命中化合物鑑定為先導化合物
• 先導藥物最適化
• 候選化合物的檢驗

第5章 全球藥物研發服務市場：依類型分類

• 市場分析、洞察與預測
• 化學服務
• 生物服務

第6章 全球藥物研發服務市場：依藥物類型分類

• 市場分析、洞察與預測
• 小分子藥物
• 生物製劑

第7章 全球藥物研發服務市場：依治療領域分類

• 市場分析、洞察與預測
• 神經病學
• 感染疾病及免疫系統疾病
• 消化器官系統疾病
• 腫瘤學
• 其他治療領域

第8章 全球藥物研發服務市場：依最終用戶分類

• 市場分析、洞察與預測
• 製藥和生物技術公司
• 學術機構
• 製造業
• 其他最終用戶

第9章 全球藥物研發服務市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第10章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第11章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Laboratory Corporation Of America Holdings
  • Charles River Laboratories International Inc
  • Thermo Fisher Scientific Inc
  • Evotec SE
  • Pharmaron Beijing Co. Ltd
  • Genscript Biotech Corporation
  • WuXi AppTec
  • Eurofins Scientific
  • Syngene International
  • Curia（Formerly AMRI）
  • Piramal Pharma Solutions

The Drug Discovery Services Market size is expected to reach USD 92.83 Billion in 2034 from USD 26.04 Billion (2025) growing at a CAGR of 15.17% during 2026-2034.

The global drug discovery services market is expanding rapidly due to the increasing demand for new and effective therapeutics across multiple disease areas. Pharmaceutical and biotechnology companies are increasingly outsourcing drug discovery processes to specialized service providers in order to reduce costs and accelerate development timelines. These services include target identification, lead optimization, screening, and preclinical research.

Technological advancements such as artificial intelligence, high-throughput screening, and advanced bioinformatics are transforming the drug discovery process. These technologies enable researchers to analyze large datasets, identify promising drug candidates more efficiently, and reduce the overall time required for drug development. As a result, outsourcing partners with advanced capabilities are gaining significant importance in the pharmaceutical ecosystem.

Future prospects for the drug discovery services market remain strong as the demand for innovative drugs continues to rise. Increasing investments in biotechnology research, expanding pharmaceutical pipelines, and the growing prevalence of chronic diseases are expected to support market growth. Collaboration between pharmaceutical companies and specialized research organizations will further drive expansion in this sector.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Process

• Target Selection
• Target Validation
• Hit-to-lead Identification
• Lead Optimization
• Candidate Validation

By Type

• Chemistry Services
• Biology Services

By Drug Type

• Small Molecule Drugs
• Biologics Drugs

By Therapeutic Area

• Neurology
• Infectious and Immune Systems Diseases
• Digestive System Diseases
• Oncology
• Other Therapeutic Areas

By End User

• Pharmaceutical & Biotechnology Companies
• Academic Institutes
• Manufacturing
• Other End Users

COMPANIES PROFILED

• Laboratory Corporation of America Holdings, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc, Evotec SE, Pharmaron Beijing Co Ltd, Genscript Biotech Corporation, WuXi AppTec, Eurofins Scientific, Syngene International, Curia formerly AMRI, Piramal Pharma Solutions
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DRUG DISCOVERY SERVICES MARKET: BY PROCESS 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Process
• 4.2. Target Selection Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Target Validation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Hit-to-lead Identification Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Lead Optimization Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Candidate Validation Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DRUG DISCOVERY SERVICES MARKET: BY TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Type
• 5.2. Chemistry Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Biology Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DRUG DISCOVERY SERVICES MARKET: BY DRUG TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Drug Type
• 6.2. Small Molecule Drugs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Biologics Drugs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DRUG DISCOVERY SERVICES MARKET: BY THERAPEUTIC AREA 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Therapeutic Area
• 7.2. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Infectious and Immune Systems Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Digestive System Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Other Therapeutic Areas Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL DRUG DISCOVERY SERVICES MARKET: BY END USER 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End User
• 8.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Manufacturing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL DRUG DISCOVERY SERVICES MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Process
  • 9.2.2 By Type
  • 9.2.3 By Drug Type
  • 9.2.4 By Therapeutic Area
  • 9.2.5 By End User
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Process
  • 9.3.2 By Type
  • 9.3.3 By Drug Type
  • 9.3.4 By Therapeutic Area
  • 9.3.5 By End User
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Process
  • 9.4.2 By Type
  • 9.4.3 By Drug Type
  • 9.4.4 By Therapeutic Area
  • 9.4.5 By End User
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Process
  • 9.5.2 By Type
  • 9.5.3 By Drug Type
  • 9.5.4 By Therapeutic Area
  • 9.5.5 By End User
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Process
  • 9.6.2 By Type
  • 9.6.3 By Drug Type
  • 9.6.4 By Therapeutic Area
  • 9.6.5 By End User
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL DRUG DISCOVERY SERVICES INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Laboratory Corporation Of America Holdings
  • 11.2.2 Charles River Laboratories International Inc
  • 11.2.3 Thermo Fisher Scientific Inc
  • 11.2.4 Evotec SE
  • 11.2.5 Pharmaron Beijing Co. Ltd
  • 11.2.6 Genscript Biotech Corporation
  • 11.2.7 WuXi AppTec
  • 11.2.8 Eurofins Scientific
  • 11.2.9 Syngene International
  • 11.2.10 Curia (Formerly AMRI)
  • 11.2.11 Piramal Pharma Solutions